Erratum: Prognostic markers in peripheral T-cell lymphoma (Curr Hematol Malig Rep DOI 10.1007/s11899-010-0062-x);Prognostic markers in peripheral T-cell lymphoma

Current Hematologic Malignancy Reports

Volumn 5, Issue 4, 2010, Pages 222-228

  Piccaluga, Pier Paolo ^a   Agostinelli, Claudio ^a   Gazzola, Anna ^a   Mannu, Claudia ^a   Bacci, Francesco ^a   Sabattini, Elena ^a   Pileri, Stefano A ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bologna score; Gene expression profile; International prognostic index; Peripheral T cell lymphoma; Prognostication; PTCL

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE;

BOLOGNA SCORE; CLINICAL FEATURE; GENE EXPRESSION PROFILING; INTERNATIONAL PROGNOSTIC INDEX; PERIPHERAL T CELL LYMPHOMA; PROGNOSIS; REVIEW; SCORING SYSTEM; TUMOR GROWTH;

EID: 77958468383     PISSN: 15588211     EISSN: 1558822X     Source Type: Journal    
DOI: 10.1007/s11899-010-0066-6     Document Type: Erratum

References (67)

1. NL Harris ES Jaffe H Stein, et al. 1994 A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 84 5 1361 1392 1:STN:280:DyaK2czkvVSmtQ%3D%3D 8068936 (Pubitemid 24273002)
2. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997, 89(11):3909-3918.
3. •• Swerdlow S, Campo E, Harris NL, et al. (eds): WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, edn 4. Lyon: IARC; 2008. This is the most recent update of the WHO classification of tumors of hematopoietic and lymphoid tissues.
4. •• Pileri S, Ralfkiaer E, Weisenburger D, et al.: Peripheral T-cell lymphoma, not otherwise specified. In WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, edn 4. Edited by Swerdlow S, Campo E, Harris NL, et al. Lyon: IARC; 2008:429. This is the original chapter on PTCL/NOS published in the WHO Classification.
5. J Vose J Armitage D Weisenburger 2008 International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes J Clin Oncol 26 25 4124 4130 10.1200/JCO.2008.16.4558 18626005 In this report, the authors describe some major findings within the International Peripheral T-Cell Lymphoma Project
6. KJ Savage NL Harris JM Vose, et al. 2008 ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project Blood 111 12 5496 5504 1:CAS:528:DC%2BD1cXnsVOkt7w%3D 10.1182/blood-2008-01-134270 18385450 In this report, the authors describe some major findings within the International Peripheral T-Cell Lymphoma Project concerning ALCL
7. AM Evens RB Gartenhaus 2004 Treatment of T-cell non-Hodgkin's lymphoma Curr Treat Options Oncol 5 4 289 303 10.1007/s11864-004-0020-8 15233906
8. A Lopez-Guillermo J Cid A Salar, et al. 1998 Peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification Ann Oncol 9 8 849 855 1:STN:280:DyaK1M%2Fgs1SgtA%3D%3D 10.1023/A:1008418727472 9789607 (Pubitemid 28440443)
9. C Gisselbrecht P Gaulard E Lepage, et al. 1998 Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas. Groupe d'Etudes des Lymphomes de l'Adulte (GELA) Blood 92 1 76 82 1:CAS:528:DyaK1cXktleruro%3D 9639502
10. Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. The Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 1997, 8(10):973-978.
11. P Went C Agostinelli A Gallamini, et al. 2006 Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score J Clin Oncol 24 16 2472 2479 1:CAS:528:DC%2BD28XmtVOmtr4%3D 10.1200/JCO.2005.03. 6327 16636342 (Pubitemid 46630624)
12. T Rudiger DD Weisenburger JR Anderson, et al. 2002 Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project Ann Oncol 13 1 140 149 1:STN:280:DC%2BD387islymsA%3D%3D 10.1093/annonc/mdf033 11863096 (Pubitemid 34436738)
13. A Zettl T Rudiger MA Konrad, et al. 2004 Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations Am J Pathol 164 5 1837 1848 1:CAS:528:DC%2BD2cXns1Kjsrs%3D 15111330
14. A Oshiro H Tagawa K Ohshima, et al. 2006 Identification of subtype-specific genomic alterations in aggressive adult T-cell leukemia/lymphoma Blood 107 11 4500 4507 1:CAS:528:DC%2BD28Xlt1Cgtro%3D 10.1182/blood-2005-09-3801 16484591 (Pubitemid 43801378)
15. S Hartmann S Gesk R Scholtysik, et al. 2010 High resolution SNP array genomic profiling of peripheral T cell lymphomas, not otherwise specified, identifies a subgroup with chromosomal aberrations affecting the REL locus Br J Haematol 148 3 402 412 10.1111/j.1365-2141.2009.07956.x 19863542
16. S Ascani PL Zinzani F Gherlinzoni, et al. 1997 Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification Ann Oncol 8 6 583 592 1:STN:280:DyaK2svgsVyhsg%3D%3D 10.1023/A:1008200307625 9261528 (Pubitemid 27359419)
17. PP Piccaluga C Agostinelli A Califano, et al. 2007 Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targets J Clin Invest 117 3 823 834 1:CAS:528:DC%2BD2sXis12htb0%3D 10.1172/JCI26833 17304354 In this article, the authors presented for the first time a global GEP study in the field of PTCLs, providing new evidence on their histogenesis and pathogenesis and proposing new therapeutic targets (Pubitemid 46348541)
18. R Piva L Agnelli E Pellegrino, et al. 2010 Gene expression profiling uncovers molecular classifiers for the recognition of anaplastic large-cell lymphoma within peripheral T-cell neoplasms J Clin Oncol 28 9 1583 1590 1:CAS:528:DC%2BC3cXltFGhtrc%3D 10.1200/JCO.2008.20.9759 20159827
19. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993, 329(14):987-994.
20. B Falini S Pileri PL Zinzani, et al. 1999 ALK+ lymphoma: clinico-pathological findings and outcome Blood 93 8 2697 2706 1:CAS:528:DyaK1MXisVGktLc%3D 10194450
21. J Suzumiya K Ohshima K Tamura, et al. 2009 The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-Cell Lymphoma Project Ann Oncol 20 4 715 721 1:STN:280:DC%2BD1M3jt1equg%3D%3D 10.1093/annonc/mdn696 19150954 This is a large study within the International Peripheral T-Cell Lymphoma Project on aggressive adult T-cell leukemia/lymphoma
22. A Gallamini C Stelitano R Calvi, et al. 2004 Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study Blood 103 7 2474 2479 1:CAS:528:DC%2BD2cXjtValu70%3D 10.1182/blood-2003-09-3080 14645001 (Pubitemid 38392996)
23. AL Cheng IJ Su YC Chen, et al. 1993 Characteristic clinicopathologic features of Epstein-Barr virus-associated peripheral T-cell lymphoma Cancer 72 3 909 916 1:STN:280:DyaK3szislenug%3D%3D 10.1002/1097-0142(19930801)72:3<909:: AID-CNCR2820720341>3.0.CO;2-O 8101471
24. PM Kluin A Feller P Gaulard, et al. 2001 Peripheral T/NK-cell lymphoma: a report of the IXth Workshop of the European Association for Haematopathology Histopathology 38 3 250 270 1:STN:280:DC%2BD3MzmvFWruw%3D%3D 10.1046/j.1365-2559.2001.01058.x 11260307 (Pubitemid 32862736)
25. J Dupuis JF Emile N Mounier, et al. 2006 Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study Blood 108 13 4163 4169 1:CAS:528:DC%2BD28XhtlWqsrjI 10.1182/blood-2006-04-017632 16902151 (Pubitemid 44913288)
26. MW Bekkenk MH Vermeer PM Jansen, et al. 2003 Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients Blood 102 6 2213 2219 1:CAS:528:DC%2BD3sXntlKrsL8%3D 10.1182/blood-2002-07-1960 12750155 (Pubitemid 37122401)
27. H Kojima Y Hasegawa K Suzukawa, et al. 2004 Clinicopathological features and prognostic factors of Japanese patients with "peripheral T-cell lymphoma, unspecified" diagnosed according to the WHO classification Leuk Res 28 12 1287 1292 10.1016/j.leukres.2004.04.016 15475070 (Pubitemid 39314408)
28. S Caulet-Maugendre M Patey E Granier, et al. 1996 Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions Anal Quant Cytol Histol 18 5 337 344 1:STN:280: DyaK2s%2FmsVOmtg%3D%3D 8908304
29. TP Miller TM Grogan S Dahlberg, et al. 1994 Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial Blood 83 6 1460 1466 1:STN:280:DyaK2c7mvFemtA%3D%3D 8123837
30. C Mochen R Giardini A Costa R Silvestrini 1997 MIB-1 and S-phase cell fraction predict survival in non-Hodgkin's lymphomas Cell Prolif 30 1 37 47 1:STN:280:DyaK2svntlKguw%3D%3D 10.1111/j.1365-2184.1997.tb00914.x 9332493
31. C Montalban G Obeso A Gallego, et al. 1993 Peripheral T-cell lymphoma: a clinicopathological study of 41 cases and evaluation of the prognostic significance of the updated Kiel classification Histopathology 22 4 303 310 1:STN:280:DyaK3s3ptlWltQ%3D%3D 10.1111/j.1365-2559.1993.tb00128.x 8514273
32. EV Sheval JV Churakova OA Dudnik IA Vorobjev 2004 Examination of the proliferative activity of tumor cells in human lymphoid neoplasms using a morphometric approach Cancer 102 3 174 185 10.1002/cncr.20341 15211477 (Pubitemid 38780603)
33. M Tiemann C Schrader W Klapper, et al. 2005 Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network Br J Haematol 131 1 29 38 10.1111/j.1365-2141.2005.05716.x 16173960 (Pubitemid 43899705)
34. J Briones E Moga I Espinosa, et al. 2009 Bcl-10 protein highly correlates with the expression of phosphorylated p65 NF-kappaB in peripheral T-cell lymphomas and is associated with clinical outcome Histopathology 54 4 478 485 10.1111/j.1365-2559.2009.03250.x 19309400
35. B Martinez-Delgado B Melendez M Cuadros, et al. 2004 Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes Clin Cancer Res 10 15 4971 4982 1:CAS:528:DC%2BD2cXmtlSitr0%3D 10.1158/1078-0432.CCR-04-0269 15297397 (Pubitemid 39099770)
36. B Martinez-Delgado M Cuadros E Honrado, et al. 2005 Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas Leukemia 19 12 2254 2263 1:CAS:528:DC%2BD2MXht1ems7nK 10.1038/sj.leu.2403960 16270046 (Pubitemid 41741622)
37. PP Piccaluga C Agostinelli PL Zinzani, et al. 2005 Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified Lancet Oncol 6 6 440 10.1016/S1470-2045(05)70213-8 15925824 (Pubitemid 40753752)
38. B Ballester O Ramuz C Gisselbrecht, et al. 2006 Gene expression profiling identifies molecular subgroups among nodal peripheral T-cell lymphomas Oncogene 25 10 1560 1570 1:CAS:528:DC%2BD28XitFGhtr4%3D 10.1038/sj.onc.1209178 16288225 (Pubitemid 43361941)
39. L de Leval DS Rickman C Thielen, et al. 2007 The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells Blood 109 11 4952 4963 10.1182/blood-2006-10-055145 17284527 In this article, the authors provided molecular evidence that AITLs and some PTCLs/NOS derive from follicular T-helper cells (Pubitemid 46827794)
40. PP Piccaluga C Agostinelli A Califano, et al. 2007 Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation Cancer Res 67 22 10703 10710 1:CAS:528:DC%2BD2sXhtlSls7jM 10.1158/0008-5472.CAN-07-1708 18006812 In this article, the authors provided molecular evidence of AITL derivation from follicular T-helper cells and showed the aberrant expression of VEGF and VEGFR2 in such tumors (Pubitemid 350145896)
41. PP Piccaluga C Agostinelli S Righi, et al. 2007 Expression of CD52 in peripheral T-cell lymphoma Haematologica 92 4 566 567 10.3324/haematol.10767 17488672 (Pubitemid 350144307)
42. L Lamant A de Reynies MM Duplantier, et al. 2007 Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes Blood 109 5 2156 2164 1:CAS:528:DC%2BD2sXjtFequ7o%3D 10.1182/blood-2006-06-028969 17077326 (Pubitemid 46348218)
43. M Cuadros SS Dave ES Jaffe, et al. 2007 Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas J Clin Oncol 25 22 3321 3329 10.1200/JCO.2006.09.4474 17577022 In this article, the authors provided evidence of the prognostic relevance of proliferation rate in PTCL/NOS, based on gene expression data (Pubitemid 47325619)
44. K Miyazaki M Yamaguchi H Imai, et al. 2009 Gene expression profiling of peripheral T-cell lymphoma including gammadelta T-cell lymphoma Blood 113 5 1071 1074 1:CAS:528:DC%2BD1MXhvVajsLc%3D 10.1182/blood-2008-07-166363 18955564
45. CA Pise-Masison M Radonovich K Dohoney, et al. 2009 Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability Blood 113 17 4016 4026 1:CAS:528:DC%2BD1MXlsVWrsbg%3D 10.1182/blood-2008-08-175901 19131553
46. A Gazzola C Bertuzzi C Agostinelli, et al. 2009 Physiological PTEN expression in peripheral T-cell lymphoma not otherwise specified Haematologica 94 7 1036 1037 10.3324/haematol.2009.006718 19508975
47. Y Huang A de Reynies L de Leval, et al. 2010 Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal-type Blood 115 6 1226 1237 1:CAS:528:DC%2BC3cXisFyrtLk%3D 10.1182/blood-2009-05-221275 19965620
48. J Iqbal DD Weisenburger TC Greiner, et al. 2010 Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma Blood 115 919 920 10.1182/blood-2009-06- 227579 This large study basically confirmed previous data and supported the idea that PTCL/NOS cases with different cellular derivation may have different clinical outcomes
49. C Rodriguez-Antona S Leskela M Zajac, et al. 2007 Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas Blood 110 9 3345 3351 1:CAS:528:DC%2BD2sXht12gt7fF 10.1182/blood-2007-02-075036 17634410 (Pubitemid 350106328)
50. C Agostinelli PP Piccaluga P Went, et al. 2008 Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies J Clin Pathol 61 11 1160 1167 1:CAS:528:DC%2BD1MXhtFyhtL8%3D 10.1136/jcp.2008. 055335 18755717
51. G Lenz LM Staudt 2010 Aggressive lymphomas N Engl J Med 362 15 1417 1429 1:CAS:528:DC%2BC3cXkslajtbY%3D 10.1056/NEJMra0807082 20393178 This is a comprehensive review on the molecular pathogenesis of aggressive B-NHL
52. L Quintanilla-Martinez JL Franklin I Guerrero, et al. 1999 Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression Hum Pathol 30 7 849 855 1:STN:280: DyaK1MzktFCmtw%3D%3D 10.1016/S0046-8177(99)90147-8 10414505 (Pubitemid 29325793)
53. K Oshimi K Kawa S Nakamura, et al. 2005 NK-cell neoplasms in Japan Hematology 10 3 237 245 10.1080/10245330400026162 16019472 (Pubitemid 41801140)
54. J Lee C Suh YH Park, et al. 2006 Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study J Clin Oncol 24 4 612 618 10.1200/JCO.2005.04.1384 16380410 (Pubitemid 46630424)
55. C Barrionuevo M Zaharia MT Martinez, et al. 2007 Extranodal NK/T-cell lymphoma, nasal type: study of clinicopathologic and prognosis factors in a series of 78 cases from Peru Appl Immunohistochem Mol Morphol 15 1 38 44 10.1097/01.pai.0000205062.27174.56 17536305 (Pubitemid 46673314)
56. Chan J, Quintanilla-Martinez L, Ferry J, Peh SC: Extranodal NK/T-cell lymphoma, nasal-type. In WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, edn 4. Edited by Swerdlow S, Campo E, Harris NL, et al. Lyon: IARC; 2008:285.
57. WY Au DD Weisenburger T Intragumtornchai, et al. 2009 Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project Blood 113 17 3931 3937 1:CAS:528:DC%2BD1MXlsVWrsLs%3D 10.1182/blood-2008-10-185256 19029440 This large study within the International Peripheral T-Cell Lymphoma Project concerns nasal and extranasal NK/T-cell lymphomas
58. YL Kwong AC Chan R Liang, et al. 1997 CD56+ NK lymphomas: clinicopathological features and prognosis Br J Haematol 97 4 821 829 1:STN:280:DyaK2szmtVWmtw%3D%3D 10.1046/j.1365-2141.1997.1462962.x 9217183
59. JK Chan 1998 Natural killer cell neoplasms Anat Pathol 3 77 145 1:STN:280:DyaK1MzhslyisQ%3D%3D 10389582
60. MM Cheung JK Chan WH Lau, et al. 2002 Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality Int J Radiat Oncol Biol Phys 54 1 182 190 12182990
61. TT Kuo LY Shih NM Tsang 2004 Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities Int J Surg Pathol 12 4 375 387 1:CAS:528:DC%2BD2cXhtVCkt7vN 10.1177/106689690401200410 15494863 (Pubitemid 39463506)
62. WY Au A Pang C Choy, et al. 2004 Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients Blood 104 1 243 249 1:CAS:528:DC%2BD2cXlslWgsb0%3D 10.1182/blood-2003-12-4197 15031209 (Pubitemid 38879864)
63. SB Ng KW Lai S Murugaya, et al. 2004 Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore Mod Pathol 17 9 1097 1107 10.1038/modpathol.3800157 15195107 (Pubitemid 39128236)
64. CS Chim SY Ma WY Au, et al. 2004 Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index Blood 103 1 216 221 1:CAS:528:DC%2BD2cXhsFGitg%3D%3D 10.1182/blood-2003-05-1401 12933580 (Pubitemid 38029941)
65. WT Huang KC Chang GC Huang, et al. 2005 Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type Haematologica 90 8 1063 1069 1:CAS:528:DC%2BD2MXhtFGltr7P 16079105
66. J Lee C Suh J Huh, et al. 2007 Effect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer/T-cell lymphoma, nasal-type Clin Cancer Res 13 11 3250 3254 1:CAS:528:DC%2BD2sXmtVajurc%3D 10.1158/1078-0432.CCR-06-2373 17545530 (Pubitemid 46944909)
67. R Suzuki J Suzumiya M Yamaguchi, et al. 2010 Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type Ann Oncol 21 5 1032 1040 1:STN:280:DC%2BC3c3ptFymtw%3D%3D 10.1093/annonc/mdp418 19850638